Report / U.S.
Published by NOISE
OB-GYNs endorse hormone therapy in first menopause guideline update since 2014
From Evening NOISE.
The American College of Obstetricians and Gynecologists released new guidelines recommending hormone replacement therapy for menopause symptoms like hot flashes, night sweats, and insomnia, its first update since 2014. The guidance calls hormone therapy's safety well-established for recently menopausal women under 60, citing newer evidence that revises concerns raised by the 2002 Women's Health Initiative, and also endorses nonhormonal drugs such as fezolinetant (Veozah), elinzanetant (Lynkuet), gabapentin, and the estrogen-bazedoxifene pill Duavee. With about 2 million US women entering menopause each year and demand for hormone therapy already rising, the guidance aims to help doctors tailor treatment and counter misinformation, though transdermal estrogen patches have faced recent shortages.
Saved versions
These dates record changes to NOISE’s copy. They are not event dates.